According to Nature Biotechnology, from 2000 to 2010, healthcare venture investing in the US yielded an Internal Rate of Return (IRR) of 15 percent for realized deals compared to four percent aggregate return for software technology ventures. Chris Fair, President of Round2Funding, knew there was an opportunity to capitalize on the healthcare companies not just in Georgia, but also across the globe.
“Raising capital can be a daunting and strenuous process, but it does not have to be,” says Fair. “By providing companies with the correct tools to successfully raise capital and connect them with the right investors, the fundraising process can be seamless.”
“With little effort on our end, Round2Funding enables us to review deal flow we may not find on our own while keeping our identity private,” says Will Loving, Altron Investments.
Round2Funding will be hosting a pitch competition, The Main Event, in Atlanta, Ga. on May 17th at the Georgia Tech Conference Center. Round2Funding is now accepting applications for The Main Event at www.round2funding.com/
Round2funding is invitation-only investment portal that directly connects vetted healthcare Companies with accredited Investors. Round2Funding was created to address the needs of early stage healthcare companies attempting to raise capital and investment institutions looking to invest directly in quality, vetted healthcare opportunities. Round2Funding aims to provide a credible alternative to the current broker dealer model. Note: Round2Funding, Inc. nor any of its current affiliates are registered broker dealers.